Evofem Biosciences Inc (OQ:EVFM)

Business Focus: Pharmaceuticals

Competitors with Recent Insider Filings
Merck & Co. (N:MRK)
Pfizer (N:PFE)
Odonate Therapeutics (OQ:ODT)
Latest 10 SEC filings (by transaction date) for EVFM within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 26th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 12/19 Jun 10/19 Barrans Russell Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,965 $6.36
Jun 12/19 Jun 10/19 Culwell Kelly Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,187 $6.36
Jun 12/19 Jun 10/19 File Justin J. Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -10,185 $6.36
Jun 12/19 Jun 10/19 Pelletier Saundra L Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -35,826 $6.36
Jun 12/19 Jun 10/19 Fitzpatrick Alexander A Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -7,777 $6.36
Jun 12/19 Jun 10/19 Invesco Ltd. Indirect Ownership Right to Purchase J - Other transaction 555,556 $0.000
Jun 12/19 Jun 10/19 Invesco Ltd. Indirect Ownership Warrants J - Other transaction -212,765 $0.000
Jun 12/19 Jun 10/19 Invesco Ltd. Indirect Ownership Common stock P - Open market or private purchase 2,222,222 $4.50
Jun 10/19 Jun 10/19 Pdl Biopharma, Inc. Direct Ownership Warrants (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 1,666,667  
Jun 10/19 Jun 10/19 Pdl Biopharma, Inc. Direct Ownership Common Stock P - Open market or private purchase 6,666,667 $4.50
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for EVFM within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 26th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 12/19 Jun 10/19 Barrans Russell Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,965 $6.36
Jun 12/19 Jun 10/19 Culwell Kelly Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,187 $6.36
Jun 12/19 Jun 10/19 File Justin J. Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -10,185 $6.36
Jun 12/19 Jun 10/19 Pelletier Saundra L Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -35,826 $6.36
Jun 12/19 Jun 10/19 Fitzpatrick Alexander A Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -7,777 $6.36
Jun 12/19 Jun 10/19 Invesco Ltd. Indirect Ownership Right to Purchase J - Other transaction 555,556 $0.000
Jun 12/19 Jun 10/19 Invesco Ltd. Indirect Ownership Warrants J - Other transaction -212,765 $0.000
Jun 12/19 Jun 10/19 Invesco Ltd. Indirect Ownership Common stock P - Open market or private purchase 2,222,222 $4.50
Jun 10/19 Jun 10/19 Pdl Biopharma, Inc. Direct Ownership Warrants (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 1,666,667  
Jun 10/19 Jun 10/19 Pdl Biopharma, Inc. Direct Ownership Common Stock P - Open market or private purchase 6,666,667 $4.50
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $EVFM

StockTwits